Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Jazz Pharmaceuticals
Hoffmann-La Roche
University of California, Irvine
Daiichi Sankyo
Brigham and Women's Hospital
MediLink Therapeutics (Suzhou) Co., Ltd.
Pfizer
Bayer
Tempus AI
UNC Lineberger Comprehensive Cancer Center
British Columbia Cancer Agency
University of California, Irvine
Elevation Oncology
Zhejiang Provincial People's Hospital
Sun Yat-sen University
Universitair Ziekenhuis Brussel
Instituto Nacional de Cancer, Brazil
Hoffmann-La Roche
OncoNano Medicine, Inc.
Jules Bordet Institute
Bayer
Sun Yat-sen University
Institut de Cancérologie de la Loire
National Institutes of Health Clinical Center (CC)
Amgen
Icahn School of Medicine at Mount Sinai
Alliance for Clinical Trials in Oncology
University of Brasilia
Sir Mortimer B. Davis - Jewish General Hospital
GE Healthcare
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Center, Korea